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Background: In this pilot study we evaluated the performance of a substitute CT (s-CT) image derived from MR
data of the brain, as a basis for optimization of intensity modulated rotational therapy, final dose calculation and
derivation of reference images for patient positioning.
Methods: S-CT images were created using a Gaussian mixture regression model on five patients previously treated
with radiotherapy. Optimizations were compared using Dmax, Dmin, Dmedian and Dmean measures for the target volume
and relevant risk structures. Final dose calculations were compared using gamma index with 1%/1 mm and 3%/3 mm
acceptance criteria. 3D geometric evaluation was conducted using the DICE similarity coefficient for bony structures. 2D
geometric comparison of digitally reconstructed radiographs (DRRs) was performed by manual delineation of relevant
structures on the s-CT DRR that were transferred to the CT DRR and compared by visual inspection.
Results: Differences for the target volumes in optimization comparisons were small in general, e.g. a mean difference
in both Dmin and Dmax within ±0.3%. For the final dose calculation gamma evaluations, 100% of the voxels passed the
1%/1 mm criterion within the PTV. Within the entire external volume between 99.4% and 100% of the voxels passed
the 3%/3 mm criterion. In the 3D geometric comparison, the DICE index varied between approximately 0.8-0.9,
depending on the position in the skull. In the 2D DRR comparisons, no appreciable visual differences were found.
Conclusions: Even though the present work involves a limited number of patients, the results provide a strong
indication that optimization and dose calculation based on s-CT data is accurate regarding both geometry and dosimetry.
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For several common patient groups in the radiotherapy
clinic, there is strong support within the scientific com-
munity for using magnetic resonance (MR) imaging as
the primary imaging modality when defining the target
volume. Examples of such patient groups are those with
prostate [1], brain [2], head and neck [3] and cervical
cancers [4]. Treatment planning, including inverse plan-
ning optimization, dose calculations and generation of
reference images for patient positioning are still dependent
on the access to computed tomography (CT) images of
the patient due to the electron density information* Correspondence: joakim.jonsson@radfys.umu.se
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unless otherwise stated.content and excellent contrast between bone and soft tis-
sue. However, a workflow in which the target volume is
defined on MR images and the treatment is planned on
CT data is dependent on the ability to align these images
in the same coordinate system, i.e. image registration. The
literature indicates that multi-modal image registration on
actual patient data is associated with uncertainties of clinic-
ally relevant magnitude, affecting the geometric accuracy of
the treatment systematically [5]. Therefore, it has been sug-
gested to use MR data exclusively for the planning of the
treatment [6-9] to avoid such spatial uncertainties. In order
to use MR data exclusively, some form of conversion of
MR image intensities into values that resemble Hounsfield
units (HU) is necessary, since dose calculations rely on the
connection between HUs and electron densities. Severall. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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dosimetric results of calculations based on MR are gener-
ally good [10-13]. The early work within the area was
based on either manual delineation of relevant anatomical
structures and assigning them bulk densities, which is
highly time consuming [10,13,14], or using a single bulk
density for the entire anatomy, i.e. that of water or mixture
of muscle and adipose tissue. Such single density conver-
sions compromises the dosimetric accuracy to a higher de-
gree than multiple bulk density assignment and makes it
impossible to generate adequate reference images for posi-
tioning [13]. The introduction of MR imaging with ultra-
short echo-times (UTE), enabled automatic separation of
bone and air on a voxel-by-voxel level [15,16]. UTE im-
ages with different contrasts, combined with a statistical
method associating the intensities in the MR images with
HUs has been shown to provide a CT-like image without
manual procedures [17]. These CT-like images can be
used as a substitute CT (s-CT) for MR only treatment
planning [18], or as basis for attenuation correction of
positron emission tomography (PET) data acquired with a
combined PET/MR scanner [19]. In the present pilot
study we evaluate the performance of an s-CT image, de-
rived from MR data using a specific method, as a basis for
optimization of intensity modulated rotational therapy,




The dosimetric comparisons in the present study sepa-
rated the optimization and dose calculation steps as illus-
trated in Figure 1. To compare the optimizations, plans
with the exact same target volume, organs at risk and
optimization constraints were derived based on CT and s-
CT data and the dose distributions were compared (A).CT OPT. RT
S-CT OPT. RT
CT RT
Figure 1 Overview of study design. Dose distributions from separate op
s-CT optimization but recalculated on the CT were compared in (B).To compare the dose calculations, the plan optimized on
the s-CT was copied to the CT study, and the final dose
calculations based on the same plan were compared (B).
Patient data and imaging
The study was approved by the institutional ethical com-
mittee. Five consecutive patients with intracranial tu-
mors (glioblastoma multiforme) referred to radiotherapy
were included in the study. This patient group under-
went both MR and CT examinations as part of their
standard preparation for radiotherapy, see Figure 2 for
an overview. For the five patients included in the study,
the MR examination was extended with two dual-echo
UTE image acquisitions, with echo-times of 0.07 and
3.42 ms. In the first acquisition, a nominal flip-angle of
10 degrees was used and the second had a nominal flip-
angle of 60 degrees. The UTE imaging was performed
with isotropic 1.3 × 1.3 × 1.3 mm3 voxels. The MR exam-
inations were performed using a 1.5 T Siemens Espree
scanner and a standard 8 channel head coil. All MR data
was distortion corrected using the 3D distortion correc-
tion provided by the vendor [20,21]. CT images were ac-
quired using a Siemens Emotion 6 (three patients) and a
GE Discovery 690 (two patients), both calibrated for use
within radiotherapy. Tube voltage was 130 kV for the
Emotion 6 and 120 kV for Discovery 690. Slice thick-
nesses varied between 2.5 mm and 3.75 mm and in-
plane resolution between 0.5 mm and 1.4 mm.
Derivation of s-CT
The s-CT was estimated using the method described by
Johansson et al. [16], with the image data from the two
dual-echo UTE scans and a T2-weighted 3D sequence
(Siemens SPACE). The patients in the present study were
not imaged in treatment position in the MR scanner.





timizations on s-CT and CT were compared in (A). Doses based on the
Figure 2 An overview of the five patients included in the study. The figure shows selected slices from a T2 weighted sequence. Lesions are
marked with white arrows.
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using a rigid Mattes mutual information image algorithm
from the Insight Toolkit (ITK). The result of each registra-
tion was verified by visual inspection.
Treatment planning
Oncentra version 4.3 (Elekta, Stockholm, Sweden), was
used to plan the treatments. A radiation oncologist (T.A)
defined the target volume (GTV) and the organs at risk
(chiasma, brainstem, pituitary, right and left lens, right and
left opticus nerve) for each patient. The same structure set
was associated with both the CT and s-CT via the previ-
ously described image registration, with the exception of
the outer contour which was derived individually for both
image sets. The optimization of the treatments was per-
formed based on both the s-CTand the CT using the exact
same optimization constraints and objectives, see Table 1.
For the comparison of the optimization results, the dose
volume histograms (DVHs) were exported for the s-CT
and CT plan. To compare the performance of the final
dose calculation on the two image sets, the plan optimized
based on the s-CT was transferred to the CT data set,
recalculated and the dose distribution was exported. Dose
calculations were performed using a pencil beam algorithm,
and a dose matrix with 1.0 × 1.0 × 1.0 mm3 resolution.Table 1 The optimization objectives used in the study
Structure Objective Weighting factor
GTV Min dose > 58 3000
PTV Min dose > 57 3000
Max dose < 63
Left lens Max dose < 5 1
Right lens Max dose < 5 1
Left opticus Max dose < 5 1
Right opticus Max dose < 5 1
Chiasma Max dose < 50 1
Brain stem Max dose < 60 1
Pituritary gland Max dose < 40 1
External Surrounding dose falloff: 60 to
30 Gy in 10 mm
1000Dosimetric evaluation
For the evaluation of the optimization results, the Dmax,
Dmin, Dmedian and Dmean doses to the PTV and OAR’s were
compared between plans optimized on CTand s-CT image
data. The evaluation of the dosimetric accuracy of the s-
CT based calculations was performed by copying the plan
optimized on the s-CT to the CT study, calculating the
resulting dose and comparing dose matrices via gamma
analysis [18] using acceptance criteria of 3%/3 mm and
1%/1 mm. Although measurement errors are absent, small
geometrical deviations may be present due to registration
inaccuracies or geometric distortions in the MR images.
Geometric evaluation
The geometric evaluation of the s-CT was performed for
the 2D case, i.e. s-CT based digitally reconstructed ra-
diographs (DRRs), as well as in 3D. Patient positioning
using 2D images and DRRs for intra-cranial treatments
is often performed by manual alignment of bony struc-
tures visible on 2D x-ray projections. The verification of
the geometric accuracy of s-CT based DRRs therefore
focused on the geometric accuracy of the depiction of
these structures. DRRs for the CT and s-CT were gener-
ated, and the structures commonly used for patient posi-
tioning were delineated on the s-CT based DRR. These
delineations were then overlaid on the CT based DRR
and the result was evaluated by visual inspection.
When using cone beam CT (CBCT) for positioning of
the patient, automatic 3D registration is often the method
of choice. Given the poor soft tissue contrast of CT and
CBCT, this registration will be dominated by the high con-
trast bony structures. Therefore, to evaluate the geometric
accuracy of the s-CT for 3D positioning, the bony struc-
tures were identified on both CT and s-CT data using an
image intensity threshold of 400 HU and the dice similar-
ity index was calculated, for individual slices as well as for
the entire volume.
Results
Dosimetric comparison - optimization
The differences between the plans optimized based on CT
and s-CT was in general very small both for target and
Table 2 Dose comparison results
Diff.Dmin(%) Diff.Dmax(%) Diff.Dmedian(%) Diff.Dmean(%)
PTV 0.3 (1.6) −0.3 (0.6) −0.1 (0.1) 0.0 (0.0)
GTV 0.8 (1.0) 0.5 (0.6) 0.3 (0.8) 0.3 (0.7)
Brainstem −5.9 (7.9) −0.4 (4.0) 1.6 (3.7) −0.4 (1.9)
Pituitary gland −0.9 (4.0) 0.9 (3.5) 0.7 (3.5) 0.1 (3.4)
Right lens 4.8 (8.6) 0.4 (6.4) 2.3 (7.8) 2.3 (7.7)
Left lens 4.6 (2.0) −5.0 (24.8) 5.2 (4.4) 5.1 (4.0)
Right opticus 1.2 (5.6) 0.6 (4.7) 1.6 ( 4.0) 2.3 (5.0)
Left opticus 4.2 (4.3) 5.1 (11.6) −2.2 (11.6) 5.0 (6.3)
Chiasma −2.1 (3.1) −0.7 (3.5) −0.7 (3.3) −1.0 (3.6)
Legend: Average differences between Dmax, Dmin, Dmedian and Dmean dose for plans optimized on CT and s-CT. The standard deviation calculated based on the five
patients are presented within brackets.
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tients fully met all optimization criteria. For the patients
(n = 3) which did not reach the 58 Gy minimum criterion
for the GTV in at least one of the two optimizations, the
average minimum dose was 57.2 for the CT optimization
and 57.7 for the s-CT optimization. For the patients which
did not fully reach the PTV related criteria (n = 5), the
average minimum dose to the PTV was 54.2 and 54.3 Gy
and the average maximum dose was 63.7 and 63.5 Gy, for
the CT and s-CT optimizations respectively. Only one of
the patients failed to fulfill any optimization criteria for
the OAR. This patient exceeded the criteria for the brain
stem, pituitary gland, chiasma and left lens. For all these
OARs, the result was slightly closer to fulfilling the criteria
in the s-CT optimization. The relative dose differences in
the OARs were greatest in the optic nerves, most likely
due to the fact that the optic nerve passes in proximity to
the nasal cavity which is very difficult to classify using
MRI in combination with the low doses to the optic nerve,
i.e. a small absolute difference in dose will yield a large
percentage error. However, none of these differences was
statistically significant.Figure 3 Anatomical CT image, dose distribution and gamma map fo
dosimetric errors. The high dose region extends into the ethmoidal andDosimetric comparison – dose calculation
The plan optimized on the s-CT data was copied to the
CT study and final dose calculation was performed based
on both s-CT and CT, and the results were compared.
100% of the voxels passed the 1%/1 mm criterion within
the PTV. Within the entire external volume between
99.4% and 100% of the voxels passed the 3%/3 mm cri-
terion. For the 1%/1 mm criterion between 93.7% and
98% of the voxels passed. An example of a gamma map
is shown in Figure 3.
Geometric comparison 2D
The s-CT based DRRs had a more blurred appearance
compared to their CT based counterparts. This was espe-
cially pronounced in areas where the projections passed
through internal air cavities. The nasal septum was not
visible on the s-CT DRR in the same way as in the CT
based DRR. For the bony structures relevant for patient
positioning at treatment, the different DRRs were deemed
clinically equivalent. There was no detectable geometrical
difference except for the slight blurring. Examples of s-CT
and CT based DRRs are shown in Figure 4.r a representative slice of the patient with the largest observed
sphenoidal sinuses.
Figure 4 Lateral and anterior projections of the s-CT data (left) and CT data (right) for a representative patient. Structures deemed
relevant for patient positioning are displayed using dashed red lines. The structures were delineated on the s-CT DRR and copied to the CT DRR.
No obvious geometric differences between the two DRRs can be detected.
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The DICE index distribution for bone with density above
400 HU as a function of the position in the z-direction
in the skull is displayed in Figure 5. The agreement be-
tween s-CT and CT increases cranially, with a DICE
index around 0.8 at the level of the caudal cerebellum to
around 0.9 at the level of central cerebrum and above.
Figure 6 shows a representative slice of the CT, the s-CT
and a difference map. It is clear that the posterior nasal
cavities are the most problematic with misclassifications
in both directions.Figure 5 The dice index as function of the position in the z-direction.Discussion
This pilot study evaluated the feasibility of using CT
equivalent data (s-CT) derived from MR images for
optimization, final dose calculation and generation of
reference images for patient positioning at treatment.
Even though the patient material was very limited (only
five patients), the results did not suggest that neither the
quality of the optimizations nor the final dose calcu-
lation are compromised using the s-CT data as input
for the treatment planning. We therefore conclude that
treatment planning based on s-CT and CT may beA 400 HU threshold was used for both CT and s-CT.
Figure 6 CT, s-CT and illustration of overlapping bony anatomy. The DICE index for the slice on display was 0.81.
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acquisition was successful. MR imaging is known to be
sensitive to motion artifacts and there is some apprehen-
sion that the quality of the s-CT may be insufficient for
a currently unknown fraction of the patients. A larger
study is needed to investigate this and to serve as basis
for the development of a patient specific quality control
method for the s-CT.
The DRRs based on s-CT data are very similar to the
golden standard – CT based DRRs. The important struc-
tures are geometrically correct and are easy to find in the
s-CT based DRRs. In 3D, a DICE coefficient between 0.8
and 0.9 was found, with the higher value for the cranial
half of the skull. This compares well with other published
methods to segment the skull from MR data. Dogdas et al.
presented a method to segment the skull based on a single
high resolution MR scan, resulting in a DICE coefficient
of on average 0.75 [22]. Wagenknecht et al. evaluated an
automatic segmentation method based on 3D MP-RAGE
or other T1 weighted MR data and presented DICE coeffi-
cients between 0.7 and 0.8 in the cranial part of the skull
with lower values caudally, using a Hounsfield threshold
of 500 HU [23].
Conclusion
In conclusion, the results of our study provide experimen-
tal proof that it is feasible to use MR based s-CTs for
optimization of the treatment plans in Oncentra. The dif-
ferences between plans optimized on s-CT and CT are
very small, well below what can be considered clinically
important, both in terms of target coverage and avoidance
of risk organs. Recalculations of s-CT based treatment
plans using CT data revealed very small dose calculation
errors. Even though the present work involves a limited
number of patients, it provides a strong indication that
optimization and dose calculation based on s-CT data is
safe and may be used in clinical practice. Other expe-
rimental studies on this method with larger number of
patients would be of major interest to improve ourknowledge and serve as a basis for development of a qual-
ity assurance strategy.
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